Swedish nuclear medicine software developer Hermes Medical Solutions and Vanderbilt University have signed an exclusive license and commercialization agreement for the Olinda/EXM dosimetry application.
Hermes will distribute the application and continue the development, regulatory, manufacturing, and commercial leadership of it. Olinda/EXM is used in the radiopharmaceutical industry and research community for internal dose calculations of radiopharmaceuticals. The new version includes new human models and nuclides, according to Hermes and Vanderbilt.
